germany's coalition government yesterday approved a proposal to ease tight restrictions on genetic engineering research the proposed amendment to the three-year-old law regulating gene technology research will remove lengthy and costly procedures which had forced the pharmaceutical industry to conduct most of its research outside germany at the moment every single genetic experiment requires a series of de-tailed documents in order to receive permission this is greatly handicapping the competitiveness of german research laboratories said mr gehrad stopa spokesman for bayer the chemical group the amendment introduces simpler registration procedures for research classified as safe for the natural and human environment over 75 per cent of genetic engineering research falls into this category and could benefit from the amendment mr gunter rexrodt the economics minister said yesterday the proposal was crucial to ensure that german pharmaceutical laboratories were competitive with those of other countries especially the us the amendment will go to parliament later this year